Is Alzheimer's disease, relentless and slow, a better target for clinical trials?

Published Date: 16 Feb 2023

According to a report by the Alzheimer's Association task force, it's time to reframe what "clinically meaningful" means and change expectations about clinical trials.

Read Full News

Latest News

Risk Factors Driving Severe Maternal Morbidity in the US

Hypertensive disorders of pregnancy, chronic hypertension, and obesity are the primary risk factors for severe maternal morbidity.

CUD, Depression Share Bidirectional Link

Cannabis use disorder has a bidirectional and clinically meaningful association with major depressive disorder, new research suggests.

Can Upadacitinib Improve Sleep Quality in Patients With RA?

Upadacitinib may improve self-reported sleep quality at 3 months in patients with rheumatoid arthritis, with sustained benefits seen over the long term.

Medicaid Expansion Tied to Pancreatic Cancer Survival

A new cohort study suggests that Medicaid expansion is associated with a lower mortality risk among patients with pancreatic cancer.

Exploring Whether GLP-1 Medications May Cause Sinusitis

Research is limited, but what has been done shows a possible connection.

Novel Drug Duo Preserves Bladder in Muscle-Invasive Cancer

Approximately 40% of patients with muscle-invasive bladder cancer achieve a clinical complete response after neoadjuvant sacituzumab govitecan plus pembrolizumab, the SURE-02 trial finds.

Todays Updates

Have the Harms of Lung Cancer Screening Been Exaggerated?

Three medical societies claim recent studies have overestimated the potential harms from lung cancer screening and may be deterring patients. Not everyone agrees.

Pretreatment Liver Tests Often Overlooked in CDK4/6 Therapy

Despite FDA package insert recommendations, most patients with breast cancer who are prescribed CDK4/6 inhibitors do not receive liver function tests before starting treatment.

Alternative Medicine for Breast Cancer: Study Raises Concern

Patients who receive both standard medical treatment and complementary and alternative therapies have higher mortality — possibly due to reduced use of endocrine therapy and radiation.

Todays Updates

Have the Harms of Lung Cancer Screening Been Exaggerated?

Three medical societies claim recent studies have overestimated the potential harms from lung cancer screening and may be deterring patients. Not everyone agrees.

Pretreatment Liver Tests Often Overlooked in CDK4/6 Therapy

Despite FDA package insert recommendations, most patients with breast cancer who are prescribed CDK4/6 inhibitors do not receive liver function tests before starting treatment.

Alternative Medicine for Breast Cancer: Study Raises Concern

Patients who receive both standard medical treatment and complementary and alternative therapies have higher mortality — possibly due to reduced use of endocrine therapy and radiation.

Latest News

Hypertensive disorders of pregnancy, chronic hypertension, and obesity are the primary risk factors for severe maternal morbidity.

Cannabis use disorder has a bidirectional and clinically meaningful association with major depressive disorder, new research suggests.

Upadacitinib may improve self-reported sleep quality at 3 months in patients with rheumatoid arthritis, with sustained benefits seen over the long term.

A new cohort study suggests that Medicaid expansion is associated with a lower mortality risk among patients with pancreatic cancer.

Research is limited, but what has been done shows a possible connection.

Approximately 40% of patients with muscle-invasive bladder cancer achieve a clinical complete response after neoadjuvant sacituzumab govitecan plus pembrolizumab, the SURE-02 trial finds.

News All Time

Semaglutide for Alzheimer’s: What the EVOKE Trials Taught Us

What happens when a promising therapy falls short? Medscape spoke with Jeffrey Cummings, MD, who led the EVOKE trials of the GLP-1 semaglutide for AD, about what the results mean — and what comes next.

How Concerning Is Microplastics-Prostate Cancer Study Link?

Experts urge caution in interpreting results of a small pilot study finding microplastics in prostate cancer tissue, calling the results provocative but preliminary.

‘Don’t Play God’ in End-of-Life Conversations

From nurses to surgeons to chaplains, readers challenge how — and by whom — the hardest conversations in medicine should happen.

AI Tool Could Help Identify Osteoporosis and Osteopenia Risk

Algorithm assesses conventional x-rays to find evidence of low bone mineral density.

Language, Weight, and Clinical Care: Why Nuance Matters

How clinicians talk about weight matters. Dr Markey explores the evolution of clinical terminology and offers insight into navigating conversations about weight with patients.

How Sugary Drinks Increase Liver Fat

Although artificial sweeteners reduce sugar exposure and don’t carry the notable risk of sugary beverages, they also aren’t metabolically neutral or liver-protective.

The Critical Need for Prenatal Sleep Apnea Screening

Dr Alison Kole highlights why screening for OSA in pregnancy is a critical, often missed opportunity to mitigate cardiometabolic risks that can last for decades after delivery.

Young Adults Report Urge to Drink After Seeing Alcohol Posts

After young adults view alcohol-related posts on social media, they report a stronger desire to drink than those who do not see such posts, especially if they find the influencers credible.

Microalgal Niches Harbor Antibiotic Resistance Genes

A recent review finds that microalgal niches in freshwater ecosystems may concentrate antibiotic resistance genes, raising environmental and public health concerns.

Rising Lung Cancer Burden Among Women

Higher drug exposure in women due to lower renal and hepatic clearance and body composition can increase efficacy but also toxicity, highlighting the need to reassess dosing.

What Are Experts’ Takes on At-Home HPV Testing?

Doctors address the pros and cons of Health Resources and Services Administration’s new guidance, including at-home self-collection for cervical cancer screening.

After Migraine, Screen for Depression and Anxiety

Migraine is linked to a higher subsequent risk for depression or anxiety; the link persists within families and is not affected by living in a more deprived area.

Is Vaginal Estrogen Safe After Endometrial Cancer?

Women who use vaginal estrogen to manage early menopause after treatment for endometrial cancer may not have an increased risk for recurrence.

Sleep Coaching Can Help Teens Sleep Longer but Not Earlier

Sleep coaching can help teens who stay up late but may not help them go to bed earlier.

Nearly Half Have PTSD After Second-Trimester Termination

Women undergoing medically indicated abortions in the second trimester may be at risk for posttraumatic stress disorder; no maternal or obstetric factors are linked to the condition.

Recommended News For You

High resolution ultrasound could enable faster prostate cancer diagnosis

Early Esophageal Cancer pCR Rates Are Raised by Neoadjuvant PD-1 Blockade.

Novel radiotracer identifies biomarker for triple-negative breast cancer

Physician Fights Insurer to Cover Her Baby's Brain Cancer Treatment

Cancer cells with thick glycocalyx barrier evade immune system better: study

Nanoparticle vaccine prevents multiple cancers and stops metastasis in mice

Research finds stark disparities in treatment and survival time for people with pancreatic cancer

Recommended Articles For You

Unlocking the Mystery of Leukemia: Exploring New Treatments and Hope for Patients 

Management of Relapsed Synovial Sarcoma: Current Treatment Strategies and Emerging Therapies 

The Importance of Understanding Your D-Dimer Levels: A Comprehensive Guide 

CEUS in Endometrial Cancer: A Tool for Early Myometrial Infiltration Detection 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Radioiodine therapy found to improve relative survival rates of differentiated thyroid cancer patients

2.

Extended Maintenance with Imatinib Enhances Disease-Free Survival in High-Risk GIST.

3.

World's premier cancer institute faces crippling cuts and chaos

4.

For treatment, the majority of cancer patients choose complementary therapies.

5.

Antibody Drug-Conjugate Shows Promising Activity in Extensive-Stage SCLC

1.

Exploring the Causes and Treatments of Thrombocytopenia: A Comprehensive Guide

2.

Cancer Vaccines In India: The Latest Hope In The Fight Against Disease

3.

Transforming Cancer Care: Metrics, Informatics, Equity, and Real-World Evidence

4.

Unlocking the Potential of Bicalutamide 50 mg: A Revolutionary New Treatment for Prostate Cancer

5.

Unveiling the Mystery Behind Castleman Disease – Understanding Its Causes and Symptoms 

1.

International Lung Cancer Congress®

2.

Future NRG Oncology Meeting

3.

Genito-Urinary Oncology Summit 2026

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Navigating the Complexities of Ph Negative ALL - Part III

2.

Efficient Management of First line ALK-rearranged NSCLC - Part II

3.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part I

4.

CDK4/6 Inhibitors Redefining Treatment for HR+/HER2- aBC In Post-Menopausal Women- A Panel Discussion

5.

Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option- Summarization of the New Perspective

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot